Nasalance Scores for Normal-speaking French Children (NONAFRA2022)

February 26, 2024 updated by: Assistance Publique - Hôpitaux de Paris

Normative Nasalance Scores for Native French-speaking Children

The velopharyngeal mechanisms (in particular the movements of the soft palate) is frequently affected by craniofacial anomalies such as cleft lip and palate. Nasofibroscopy is frequently used in clinical care to assess the velopharyngeal function because it allows for direct visualization of the velopharyngeal port. However, it is an invasive procedure that could not be tolerated well by children.

Nasometry is a non-invasive acoustic measurement technique which can be used to objectively assess a velopharyngeal dysfunction (whether it can be heard or not), and thus supplement the perceptual evaluation conducted by a trained clinician.

The main objective of this study is to establish normative nasalance scores with the KayPENTAX Nasometer (Nasometer II 6450 model) for native French-speaking children between 8 and 10 years old.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The velopharyngeal mechanism (in particular the movements of the soft palate) is frequently affected by craniofacial anomalies such as cleft lip and palate and it needs to be assessed. Indeed, the velopharyngeal sphincter has to be efficient in order to properly isolate the oral cavity from the nasal cavity. Thus, the nasal cavity is protected during swallowing (preventing food or liquids from passing through the nose). It also ensures a correct phonation and articulation of oral phonemes.

A perceptual evaluation of the velopharyngeal function is always conducted by a clinician. But it is a subjective assessment which may need to be supplemented by an objective instrumental assessment. Nasofibroscopy is frequently used in clinical care to evaluate the velopharyngeal function because it allows for direct visualization of the velopharyngeal port. However, it is an invasive procedure that could not be tolerated well by children.

Nasometry on the other hand is a non-invasive acoustic measurement technique. It is based on the relation between nasal and oral acoustic energy and determines a nasalance score. Calculated in real time during speech production, the nasalance is a measure expressed as a percentage : (nasal acoustic energy) / (sum of oral and nasal acoustic energy). The device computing the nasalance score is called a Nasometer.

Thus, in addition to the speech therapist's perceptual evaluation, nasometry can be used to objectively assess and quantify a velopharyngeal dysfunction whether it can be heard or not. However in order to determine if a patient's nasalance score is pathological or not, it must be compared to standardized norms. Yet presently, there are no normative nasalance data for French-speaking children. The main objective of this study is to establish normative nasalance scores with the KayPENTAX Nasometer (Nasometer II 6450 model) for native French-speaking children between 8 and 10 years old.

Study Type

Observational

Enrollment (Actual)

131

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Paris, France, 75015
        • Hopital Necker-Enfants Malades

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 10 years (Child)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients followed by the Pediatric ENT department of Necker-Enfants Malades hospital

Description

Inclusion Criteria:

  • Holders of parental authority and patients informed and not opposing their participation in the study
  • Patients aged 8 to 10 years old
  • native-French speakers (French from France including the French overseas departments and territories)
  • Educated in France in an ordinary environment
  • Patients without a cleft
  • Patients with a cleft : patients with a hard and/or soft palate cleft and for whom the perceptual speech-language pathology evaluation revealed a velopharyngeal insufficiency

Exclusion Criteria:

Patients without developmental speech disorder (including articulation disorder) or hearing impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients without cleft
Patients without developmental speech disorder (including articulation disorder) or hearing impairment
Repetition of several stimuli (syllables, sentences ) in the microphones of the Nasometer
Patients with a cleft
Patients with a hard and/or soft palate cleft and for whom the perceptual speech-language pathology evaluation revealed a velopharyngeal insufficiency
Repetition of several stimuli (syllables, sentences ) in the microphones of the Nasometer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nasalance score for each stimulus
Time Frame: Day 0
Average value of nasalance score for each stimulus
Day 0
Nasalance score per context
Time Frame: Day 0
Average value of nasalance score per context (oral - nasal)
Day 0
Nasalance score of the nasalance distance
Time Frame: Day 0
Average value of the nasalance distance (difference between the average in a nasal context and the average in an oral context)
Day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of the context on the nasalance scores
Time Frame: Day 0
Effect of the context (oral / nasal) on the nasalance scores: comparison of the mean, minimum and maximum measurements between the two contexts
Day 0
Speech stimulus length effect on the nasalance scores
Time Frame: Day 0
Check whether there is a speech stimulus length effect: are the nasalance scores comparable between repeating an oral short sentence and an oral long sentence, provided that the phonemic distribution is identical? Comparison of the average, minimum and maximum scores between the two stimuli
Day 0
Effect of the phonetic context on the nasalance scores
Time Frame: Day 0
Check if there is an effect of the phonetic context (types of vowels and consonants) on the nasalance scores: comparison of the mean, minimum and maximum scores between for example high vowels ([i]) and low ([a]) or between voiceless ([k]) and voiced ([g]) consonants
Day 0
Test-retest reliability of the nasalance scores
Time Frame: Day 0
Evaluate the test-retest reliability: selection of a few subjects who will repeat the stimuli twice. Analyze if there is a significant difference between the two repetitions
Day 0
Most relevant stimuli for a nasometric protocol
Time Frame: Day 0
Validate the nasometric evaluation protocol for its clinical use : on the basis of speech therapy assessment results, determine the best time / efficiency ratio and choose the most relevant stimuli in order to have the maximum information in a minimum of time
Day 0
Analysis of acoustic signals captured by standard microphones
Time Frame: Day 0
Compare the nasalance score obtained with the Nasometer with a nasalance score calculated on the basis of acoustic signals captured at the same time by standard microphones placed on the Nasometer plate: compare the average, minimum and maximum values between the two recordings of acoustic signals
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Natacha KADLUB, MD, PhD, Assistance Publique - Hôpitaux de Paris
  • Study Director: Cécile CHAPUIS-VANDENBOGAERDE, MD, Assistance Publique - Hôpitaux de Paris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 16, 2021

Primary Completion (Actual)

January 24, 2024

Study Completion (Actual)

January 24, 2024

Study Registration Dates

First Submitted

June 14, 2021

First Submitted That Met QC Criteria

June 14, 2021

First Posted (Actual)

June 22, 2021

Study Record Updates

Last Update Posted (Actual)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 26, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • APHP210445
  • 2021-A00452-39 (Other Identifier: IDRCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Resonance Disorder

3
Subscribe